Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria

BACKGROUND: Eligibility criteria that result in the exclusion of a substantial number of patients from randomized trials jeopardize the generalizability of treatment effect to much of the clinical population. This is important when evaluating opioid substitution and antagonist therapies (OSATs), esp...

Descripción completa

Detalles Bibliográficos
Autores principales: Dennis, Brittany B., Roshanov, Pavel S., Naji, Leen, Bawor, Monica, Paul, James, Plater, Carolyn, Pare, Guillaume, Worster, Andrew, Varenbut, Michael, Daiter, Jeff, Marsh, David C., Desai, Dipika, Samaan, Zainab, Thabane, Lehana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618532/
https://www.ncbi.nlm.nih.gov/pubmed/26489415
http://dx.doi.org/10.1186/s13063-015-0942-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618532/
https://www.ncbi.nlm.nih.gov/pubmed/26489415
http://dx.doi.org/10.1186/s13063-015-0942-4

Ejemplares similares